These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 8061335

  • 1. Evaluation of two therapeutic regimens for the treatment of Helicobacter pylori infection.
    Tucci A, Poli L, Gasperoni S, Varoli O, Paparo GF, De Giorgio R, Stanghellini V, Corinaldesi R.
    Ital J Gastroenterol; 1994 Apr; 26(3):107-10. PubMed ID: 8061335
    [Abstract] [Full Text] [Related]

  • 2. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN, Hahm JS, Kim HJ.
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of the efficacy and tolerability of four different therapeutic regimens for the Helicobacter pylori eradication.
    Tursi A, Cammarota G, Montalto M, Papa A, Cuoco L, Veneto GM, Cannizzaro O, Fedeli G, Gasbarrini G.
    Panminerva Med; 1996 Sep; 38(3):145-9. PubMed ID: 9009677
    [Abstract] [Full Text] [Related]

  • 4. The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication.
    Avidan B, Melzer E, Keller N, Bar-Meir S.
    Isr Med Assoc J; 2001 Mar; 3(3):163-5. PubMed ID: 11303370
    [Abstract] [Full Text] [Related]

  • 5. [new one-week triple therapies with metronidazole for the eradication of Helicobacter pylori: clarithromycin or amoxycillin as the second antibiotic].
    Gisbert JP, Boixeda D, Martín de Argila C, Redondo C, Moreno L, Abraira V, García Plaza A.
    Med Clin (Barc); 1998 Jan 17; 110(1):1-5. PubMed ID: 9527978
    [Abstract] [Full Text] [Related]

  • 6. Triple therapy vs. amoxicillin plus omeprazole for treatment of Helicobacter pylori infection: a multicenter, prospective, randomized, controlled study of efficacy and side effects.
    Thijs JC, van Zwet AA, Moolenaar W, Wolfhagen MJ, ten Bokkel Huinink J.
    Am J Gastroenterol; 1996 Jan 17; 91(1):93-7. PubMed ID: 8561152
    [Abstract] [Full Text] [Related]

  • 7. Comparison of three different second-line quadruple therapies including bismuth subcitrate in Turkish patients with non-ulcer dyspepsia who failed to eradicate Helicobacter pylori with a 14-day standard first-line therapy.
    Uygun A, Ozel AM, Yildiz O, Aslan M, Yesilova Z, Erdil A, Bagci S, Gunhan O.
    J Gastroenterol Hepatol; 2008 Jan 17; 23(1):42-5. PubMed ID: 17559359
    [Abstract] [Full Text] [Related]

  • 8. Anti-Helicobacter pylori treatment in bleeding ulcers: randomized controlled trial comparing 2-day versus 7-day bismuth quadruple therapy.
    Kung NN, Sung JJ, Yuen NW, Ng PW, Wong KC, Chung EC, Lim BH, Choi CH, Li TH, Ma HC, Kwok SP.
    Am J Gastroenterol; 1997 Mar 17; 92(3):438-41. PubMed ID: 9068464
    [Abstract] [Full Text] [Related]

  • 9. Weekend therapy for the treatment of Helicobacter pylori infection.
    Tucci A, Poli L, Paparo GF, Bocus P, Togliani T, Mazzoni C, Orcioni GF, Agosti R, Grigioni WF, Sottili S, Caletti G.
    Am J Gastroenterol; 1998 May 17; 93(5):737-42. PubMed ID: 9625119
    [Abstract] [Full Text] [Related]

  • 10. [Effectiveness of triple therapy to eradicate H. pylori in patients after failed therapy with omeprazole/amoxicillin].
    Zala G, Schwery S, Giezendanner S, Flury R, Wüst J, Meyenberger C, Wirth HP.
    Schweiz Med Wochenschr; 1996 Feb 03; 126(5):153-8. PubMed ID: 8685685
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of a new bismuth-free triple therapy in nude mice and humans.
    Karita M, Tsuda M, Okita K, Sugiyama T, Nakazawa T.
    Eur J Gastroenterol Hepatol; 1995 Aug 03; 7 Suppl 1():S31-4. PubMed ID: 8574732
    [Abstract] [Full Text] [Related]

  • 12. Randomized clinical trial comparing two one-week triple-therapy regimens for the eradication of Helicobacter pylori infection and duodenal ulcer healing.
    Forné M, Viver JM, Esteve M, Fernández-Bañares F, Lite J, Espinós JC, Quintana S, Salas A, Garau J.
    Am J Gastroenterol; 1998 Jan 03; 93(1):35-8. PubMed ID: 9448170
    [Abstract] [Full Text] [Related]

  • 13. Helicobacter pylori gastritis and non-ulcer dyspepsia in childhood. Efficacy of one-week triple antimicrobial therapy in eradicating the organism.
    Cucchiara S, Salvia G, Az-Zeqeh N, D'Armiento FD, De Petra MR, Rapagiolo S, Campanozzi A, Emiliano M.
    Ital J Gastroenterol; 1996 Jan 03; 28(8):430-5. PubMed ID: 9032584
    [Abstract] [Full Text] [Related]

  • 14. A comparison between omeprazole-based triple therapy and bismuth-based triple therapy for the treatment of Helicobacter pylori infection: a prospective randomized 1-yr follow-up study.
    Lerang F, Moum B, Ragnhildstveit E, Haug JB, Hauge T, Tolås P, Aubert E, Henriksen M, Efskind PS, Nicolaysen K, Søberg T, Odegaard A, Berge T.
    Am J Gastroenterol; 1997 Apr 03; 92(4):653-8. PubMed ID: 9128317
    [Abstract] [Full Text] [Related]

  • 15. Antimicrobial therapy for Helicobacter pylori infection versus long-term maintenance antisecretion treatment in the prevention of recurrent hemorrhage from peptic ulcer: prospective nonrandomized trial on 125 patients.
    Santander C, Grávalos RG, Gómez-Cedenilla A, Cantero J, Pajares JM.
    Am J Gastroenterol; 1996 Aug 03; 91(8):1549-52. PubMed ID: 8759659
    [Abstract] [Full Text] [Related]

  • 16. Effect of eradication of Helicobacter pylori on serum pepsinogen I, gastrin, and insulin in duodenal ulcer patients: a 12-month follow-up study.
    Chen TS, Tsay SH, Chang FY, Lee SD.
    Am J Gastroenterol; 1994 Sep 03; 89(9):1511-4. PubMed ID: 8079929
    [Abstract] [Full Text] [Related]

  • 17. The role of screening for Helicobacter pylori in patients with duodenal ulceration in the primary health care setting.
    Rosengren H, Polson RJ.
    Br J Gen Pract; 1996 Mar 03; 46(404):177-9. PubMed ID: 8731626
    [Abstract] [Full Text] [Related]

  • 18. One-week ranitidine bismuth citrate versus colloidal bismuth subcitrate-based anti-Helicobacter triple therapy: a prospective randomized controlled trial.
    Kung NN, Sung JJ, Yuen NW, Li TH, Ng PW, Lai WM, Lui YH, Lam KN, Choi CH, Leung EM.
    Am J Gastroenterol; 1999 Mar 03; 94(3):721-4. PubMed ID: 10086657
    [Abstract] [Full Text] [Related]

  • 19. A four-year follow-up of duodenal ulcer patients after Helicobacter pylori eradication.
    Tepes B, Kavcic B, Gubina M, Krizman I.
    Hepatogastroenterology; 1999 Mar 03; 46(27):1746-50. PubMed ID: 10430336
    [Abstract] [Full Text] [Related]

  • 20. One-week triple therapy with ranitidine bismuth citrate, clarithromycin and metronidazole versus two-week dual therapy with ranitidine bismuth citrate and clarithromycin for Helicobacter pylori infection: a randomized, clinical trial.
    van der Wouden EJ, Thijs JC, van Zwet AA, Kooy A, Kleibeuker JH.
    Am J Gastroenterol; 1998 Aug 03; 93(8):1228-31. PubMed ID: 9707042
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.